KMWM
TMO icon

Keudell/Morrison Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Keudell/Morrison Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
498
+24
+5% +$11.5K 0.05% 223
2026
Q1 		$233K Buy
474
+28
+6% +$15.2K 0.05% 213
2025
Q4 		$258K Buy
+446
New +$252K 0.05% 195
2025
Q2 		$262K Sell
646
-307
-32% -$128K 0.06% 184
2025
Q1 		$474K Sell
953
-1
-0.1% -$542 0.11% 115
2024
Q4 		$496K Sell
954
-173
-15% -$95.1K 0.13% 106
2024
Q3 		$697K Buy
1,127
+1
+0.1% +$592 0.19% 90
2024
Q2 		$623K Buy
1,126
+120
+12% +$68.7K 0.18% 96
2024
Q1 		$585K Buy
1,006
+366
+57% +$205K 0.18% 99
2023
Q4 		$340K Sell
640
-87
-12% -$42.1K 0.11% 141
2023
Q3 		$368K Buy
727
+24
+3% +$12.8K 0.11% 121
2023
Q2 		$367K Sell
703
-59
-8% -$31.8K 0.11% 124
2023
Q1 		$439K Sell
762
-5
-0.7% -$2.82K 0.13% 103
2022
Q4 		$422K Buy
767
+143
+23% +$75.8K 0.14% 100
2022
Q3 		$316K Buy
624
+6
+1% +$3.36K 0.12% 127
2022
Q2 		$336K Sell
618
-63
-9% -$34.7K 0.12% 125
2022
Q1 		$402K Buy
681
+5
+0.7% +$2.87K 0.17% 118
2021
Q4 		$451K Sell
676
-138
-17% -$86.2K 0.18% 105
2021
Q3 		$465K Sell
814
-1
-0.1% -$549 0.2% 106
2021
Q2 		$411K Sell
815
-12
-1% -$5.66K 0.23% 110
2021
Q1 		$377K Sell
827
-141
-15% -$67.3K 0.22% 112
2020
Q4 		$451K Hold
968
– – 0.29% 96
2020
Q3 		$427K Sell
968
-22
-2% -$9.09K 0.27% 89
2020
Q2 		$359K Sell
990
-16
-2% -$5.36K 0.3% 96
2020
Q1 		$285K Sell
1,006
-30
-3% -$9.46K 0.28% 105
2019
Q4 		$337K Buy
1,036
+23
+2% +$6.97K 0.23% 107
2019
Q3 		$295K Hold
1,013
– – 0.24% 112
2019
Q2 		$278K Sell
1,013
-11
-1% -$3.03K 0.24% 113
2019
Q1 		$280K Buy
+1,024
New +$255K 0.25% 105

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Keudell/Morrison Wealth Management's TMO Position: Q2 2026 in Review

Keudell/Morrison Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 5.1% in Q2 2026, buying an estimated $11.5K and bringing the position to 498 shares worth $250K. The position accounts for 0.05% of the portfolio, ranked #223.

Keudell/Morrison Wealth Management first reported a position in TMO in Q1 2019 and has held it in 29 quarters since. The position peaked at $697K in Q3 2024. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Keudell/Morrison Wealth Management held 498 shares of Thermo Fisher Scientific worth $250K as of Q2 2026.
  • Keudell/Morrison Wealth Management bought 24 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.5K.
  • Thermo Fisher Scientific made up 0.05% of Keudell/Morrison Wealth Management's portfolio in Q2 2026, its #223 holding.
  • Keudell/Morrison Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 29 quarters since.
  • Keudell/Morrison Wealth Management's Thermo Fisher Scientific position peaked at $697K in Q3 2024.
  • 429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Keudell/Morrison Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.